REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad Clinica del Sistema Nervioso Limitada (Colombia)

Main Activities: Hospitals
Full name: Unidad Clinica del Sistema Nervioso Limitada Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unidad Clinica del Sistema Nervioso Limitada is a company based in Colombia, with its head office in Villavicencio. The enterprise operates in the Hospitals industry. It was incorporated on April 12, 1997. It currently has a total number of 35 (2012) employees. In 2025, the company reported a net sales revenue increase of 13.01%. A growth of 3.63% was recorded in its total assets. In, 2025, the company’s net profit margin decreased by 0.48%.

Headquarters
Calle 33 N 42 30
Villavicencio; Meta;

Contact Details: Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.
Registered Capital:
Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.
Financial Auditors:
Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.
Incorporation Date:
April 12, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Unidad Clinica del Sistema Nervioso Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.01%
Total Operating Revenue
13.01%
Operating Profit
11.76%
EBITDA
12.86%
Net Profit/Loss for the Period
9.56%
Total Assets
3.63%
Total Equity
12.97%
Operating Profit Margin
-0.4%
Net Profit Margin
-0.48%
Return on Equity (ROE)
-0.36%
Debt / Equity
-7.61%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?